Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05216133

Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)

AERODIGESTIVE DISEASE IN THE WORLD TRADE CENTER EXPOSED FDNY COHORT: a Single Center Observational Study of Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
Male
Age
37 Years – 90 Years
Healthy volunteers
Not accepted

Summary

A majority of Fire Department of New York (FDNY) World Trade Center (WTC) exposed rescue and recovery workers developed gastroesophageal reflux disease (GERD), a risk factor for Barrett's Esophagus (BE) and subsequent esophageal cancer. There is diminished health-related quality of life and productivity associated with aerodigestive diseases such as GERD and BE. This proposal will leverage the longitudinally phenotyped WTC exposed cohort, validate biomarkers of WTC-aerodigestive disease, and develop novel, noninvasive disease phenotyping of premalignant diseases such as BE, and identify potential targeted therapeutics to improve care.

Conditions

Timeline

Start date
2023-03-22
Primary completion
2027-06-01
Completion
2027-07-01
First posted
2022-01-31
Last updated
2025-06-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05216133. Inclusion in this directory is not an endorsement.